Patten & Patten Inc Novartis Ag Transaction History

Patten & Patten Inc

  • $1.43 Billion
  • Q3 2024

A detailed history of Patten & Patten Inc transactions in Novartis Ag stock. As of the latest transaction made, Patten & Patten Inc holds 32,685 shares of NVS stock, worth $3.37 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
32,685
Previous 34,580 5.48%
Holding current value
$3.37 Million
Previous $3.68 Million 2.12%
% of portfolio
0.26%
Previous 0.26%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024
SELL
$106.13 - $120.89 $201,116 - $229,086
-1,895 Reduced 5.48%
32,685 $3.76 Million
Q2 2024

Aug 13, 2024
SELL
$92.57 - $107.37 $85,164 - $98,780
-920 Reduced 2.59%
34,580 $3.68 Million
Q1 2024

May 10, 2024
SELL
$95.27 - $108.47 $9,527 - $10,847
-100 Reduced 0.28%
35,500 $3.43 Million
Q4 2023

Jan 23, 2024
SELL
$92.27 - $101.54 $171,622 - $188,864
-1,860 Reduced 4.97%
35,600 $3.59 Million
Q3 2023

Oct 27, 2023
BUY
$94.73 - $105.13 $53,048 - $58,872
560 Added 1.52%
37,460 $3.82 Million
Q2 2023

Jul 14, 2023
BUY
$92.52 - $104.91 $42,281 - $47,943
457 Added 1.25%
36,900 $3.72 Million
Q1 2023

Apr 25, 2023
SELL
$80.03 - $92.81 $811,424 - $941,000
-10,139 Reduced 21.77%
36,443 $3.35 Million
Q4 2022

Feb 01, 2023
SELL
$75.55 - $92.52 $253,545 - $310,497
-3,356 Reduced 6.72%
46,582 $4.23 Million
Q3 2022

Oct 19, 2022
SELL
$74.61 - $87.26 $122,882 - $143,717
-1,647 Reduced 3.19%
49,938 $3.8 Million
Q2 2022

Aug 02, 2022
SELL
$80.52 - $93.75 $220,463 - $256,687
-2,738 Reduced 5.04%
51,585 $4.36 Million
Q1 2022

Apr 25, 2022
SELL
$80.11 - $90.62 $10,975 - $12,414
-137 Reduced 0.25%
54,323 $4.77 Million
Q4 2021

Jan 26, 2022
SELL
$79.7 - $88.13 $200,684 - $221,911
-2,518 Reduced 4.42%
54,460 $4.76 Million
Q3 2021

Oct 22, 2021
SELL
$81.78 - $95.14 $172,555 - $200,745
-2,110 Reduced 3.57%
56,978 $4.66 Million
Q2 2021

Jul 13, 2021
SELL
$85.24 - $94.15 $247,963 - $273,882
-2,909 Reduced 4.69%
59,088 $5.39 Million
Q1 2021

Apr 23, 2021
SELL
$83.5 - $98.47 $147,962 - $174,488
-1,772 Reduced 2.78%
61,997 $5.3 Million
Q4 2020

Jan 19, 2021
SELL
$78.07 - $94.43 $156,374 - $189,143
-2,003 Reduced 3.05%
63,769 $6.02 Million
Q3 2020

Oct 08, 2020
SELL
$82.14 - $91.0 $14,045 - $15,561
-171 Reduced 0.26%
65,772 $5.72 Million
Q2 2020

Jul 21, 2020
SELL
$80.93 - $91.1 $42,326 - $47,645
-523 Reduced 0.79%
65,943 $5.76 Million
Q1 2020

Apr 16, 2020
SELL
$70.67 - $99.01 $219,713 - $307,822
-3,109 Reduced 4.47%
66,466 $5.48 Million
Q4 2019

Jan 13, 2020
SELL
$84.35 - $95.37 $6,410 - $7,248
-76 Reduced 0.11%
69,575 $6.59 Million
Q3 2019

Oct 15, 2019
SELL
$85.54 - $94.26 $208,546 - $229,805
-2,438 Reduced 3.38%
69,651 $6.05 Million
Q2 2019

Jul 11, 2019
BUY
$75.4 - $92.8 $107,595 - $132,425
1,427 Added 2.02%
72,089 $6.58 Million
Q1 2019

Apr 23, 2019
BUY
$75.32 - $86.15 $192,969 - $220,716
2,562 Added 3.76%
70,662 $6.79 Million
Q4 2018

Jan 17, 2019
BUY
$73.66 - $82.02 $243,814 - $271,486
3,310 Added 5.11%
68,100 $5.84 Million
Q3 2018

Oct 17, 2018
SELL
$66.94 - $77.43 $187,967 - $217,423
-2,808 Reduced 4.15%
64,790 $5.58 Million
Q2 2018

Jul 18, 2018
SELL
$64.91 - $73.36 $455,668 - $514,987
-7,020 Reduced 9.41%
67,598 $5.11 Million
Q1 2018

Apr 20, 2018
BUY
$70.39 - $84.15 $7,109 - $8,499
101 Added 0.14%
74,618 $6.03 Million
Q4 2017

Jan 22, 2018
SELL
$72.33 - $77.64 $316,299 - $339,519
-4,373 Reduced 5.54%
74,517 $6.26 Million
Q3 2017

Oct 12, 2017
BUY
$74.14 - $77.27 $5.85 Million - $6.1 Million
78,890
78,890 $6.77 Million

Others Institutions Holding NVS

# of Institutions
1,433
Shares Held
133M
Call Options Held
1.12M
Put Options Held
1.83M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $222B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Patten & Patten Inc Portfolio

Follow Patten & Patten Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Patten & Patten Inc, based on Form 13F filings with the SEC.

News

Stay updated on Patten & Patten Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email